http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25575066

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 7
issn 1178-2048
pageRange 821-7
publicationName Vascular Health and Risk Management
startingPage 821
bibliographicCitation Destro M, Crikelair N, Yen J, Glazer R. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients. Vasc Health Risk Manag. 2010 Sep 07;6():821–7. PMID: 20859551; PMCID: PMC2941793.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8910171ebfc85c21f9e10d75e370c337
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbffa2cdbe711458df0dbc49ae6a6fb7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34f72636fd83eadd78b41e54f0c9da5e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ad1645f92fb4848392eb40915c0509e
date 2010-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2941793
https://doi.org/10.2147/vhrm.s11522
https://pubmed.ncbi.nlm.nih.gov/20859551
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33092
https://portal.issn.org/resource/ISSN/1178-2048
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients
discusses http://id.nlm.nih.gov/mesh/M0021253
http://id.nlm.nih.gov/mesh/M0022497
http://id.nlm.nih.gov/mesh/M0456879
http://id.nlm.nih.gov/mesh/M0010703
http://id.nlm.nih.gov/mesh/M0217346
http://id.nlm.nih.gov/mesh/M0003165
http://id.nlm.nih.gov/mesh/M0001456
http://id.nlm.nih.gov/mesh/M0026284
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D013777Q000627
http://id.nlm.nih.gov/mesh/D014633Q000031
http://id.nlm.nih.gov/mesh/D006852Q000627
http://id.nlm.nih.gov/mesh/D017311Q000627
http://id.nlm.nih.gov/mesh/D006973Q000188
http://id.nlm.nih.gov/mesh/D000959Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002121Q000008
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D014633Q000627
http://id.nlm.nih.gov/mesh/D013777Q000008
http://id.nlm.nih.gov/mesh/D047228Q000008
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D001794Q000187
http://id.nlm.nih.gov/mesh/D047228Q000627
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D006852Q000008
http://id.nlm.nih.gov/mesh/D017311Q000008
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D000068756
http://id.nlm.nih.gov/mesh/D000959Q000008
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D014633Q000008
http://id.nlm.nih.gov/mesh/D002121Q000627
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6287
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8135
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11354874
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128281397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129815624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128458032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127387957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128351234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128961263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128776154

Total number of triples: 71.